Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,021) with videos related to
Page
of 103
Sort By:
Cancer Cell
|
March 16, 2005
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
Charles G Drake, Amy D H Doody, Marianne A Mihalyo, et al.
Circulation
|
August 19, 2007
Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo
Fangwen Rao, Lian Zhang, Jennifer Wessel, et al.
Annals of the New York Academy of Sciences
|
January 6, 2009
Adrenergic polymorphism and the human stress response
Fangwen Rao, Lian Zhang, Jennifer Wessel, et al.
Cancer Biology & Therapy
|
September 13, 2013
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
JianMin Lin, Jared L Spidel, Christopher J Maddage, et al.
Circulation
|
April 18, 2007
Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension
Fangwen Rao, Gen Wen, Jiaur R Gayen, et al.
Clinical Radiology
|
January 20, 2026
IO1-UK: a cross-sectional study to re-evaluate the provision of interventional oncology services across the United Kingdom
D Velazquez-Pimentel, J Pancholi, P Jenkins, et al.
Brain and Cognition
|
December 21, 2023
Validation of the cognitive section of the Penn computerized adaptive test for neurocognitive and clinical psychopathology assessment (CAT-CCNB)
Akira Di Sandro, Tyler M Moore, Eirini Zoupou, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2001
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility
A Guzman-Perez, R T Wester, M C Allen, et al.
Journal for Immunotherapy of Cancer
|
June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Yousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Mayo Clinic Proceedings
|
July 25, 2000
Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity
B M Balsiger, F P Kennedy, H S Abu-Lebdeh, et al.
Page
of 103
Search research articles
Search
Showing results (991-1000 of 1,021) with videos related to
Sort By:
Page
of 103
Cancer Cell
|
March 16, 2005
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
Charles G Drake, Amy D H Doody, Marianne A Mihalyo, et al.
Circulation
|
August 19, 2007
Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo
Fangwen Rao, Lian Zhang, Jennifer Wessel, et al.
Annals of the New York Academy of Sciences
|
January 6, 2009
Adrenergic polymorphism and the human stress response
Fangwen Rao, Lian Zhang, Jennifer Wessel, et al.
Cancer Biology & Therapy
|
September 13, 2013
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
JianMin Lin, Jared L Spidel, Christopher J Maddage, et al.
Circulation
|
April 18, 2007
Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension
Fangwen Rao, Gen Wen, Jiaur R Gayen, et al.
Clinical Radiology
|
January 20, 2026
IO1-UK: a cross-sectional study to re-evaluate the provision of interventional oncology services across the United Kingdom
D Velazquez-Pimentel, J Pancholi, P Jenkins, et al.
Brain and Cognition
|
December 21, 2023
Validation of the cognitive section of the Penn computerized adaptive test for neurocognitive and clinical psychopathology assessment (CAT-CCNB)
Akira Di Sandro, Tyler M Moore, Eirini Zoupou, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2001
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility
A Guzman-Perez, R T Wester, M C Allen, et al.
Journal for Immunotherapy of Cancer
|
June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Yousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Mayo Clinic Proceedings
|
July 25, 2000
Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity
B M Balsiger, F P Kennedy, H S Abu-Lebdeh, et al.
Page
of 103